Perfil clínico-nutricional de pacientes com doença hepática gordurosa associada à disfunção metabólica atendidos em um hospital de Maceió

Abstract

The metabolic dysfunction-associated fatty liver disease (MAFDL) is characterized by the presence of liver steatosis accompanied by overweight or obesity, DMT2, or evidence of metabolic dysregulation. It can progress from simple steatosis to steatohepatitis and, in some cases, cirrhosis, liver failure, and hepatocellular carcinoma (HCC). This present study aimed to outline the clinical-nutritional profile of patients with DHGADM treated at the nutrition and gastroenterology outpatient clinic of Hospital Universitário Professor Alberto Antunes. A cross-sectional study was carried out with the collection of socioeconomic, clinical, and nutritional data recorded in electronic medical records, of patients with MAFDL of both sexes, aged 18 or over, treated between January of 2017 to August of 2019. Out of the 20 patients, 18 (90%) were female, with an average age of 57.45 ± 6.36 years, 9 (45%) of whom were elderly, 18 (90%) were hypertensive and/or diabetic, 6 (30%) presented a report for grade 1 steatosis, 5 (25%) grade 2 steatosis, 4 (20%) grade 3 steatosis, 9 (45%) complained about abdominal pain, 7 (35%) were adept to some type of food restriction, 17 (85%) were overweight or obese. Studies that evaluate the clinical and nutritional profile of patients with MAFDL are necessary to contribute to the use of important strategies and control of risk factors that contribute to the predisposition of MAFDL and/or its progression.